Why Providers Are Turning to KEFUNOVA™, a new 5-FU and Calcipotriene Combination for Actinic Keratosis and Superficial Basal Cell Carcinoma Patients
SKNV Rx Insights Why Providers Are Turning to KEFUNOVA™, a new 5-FU and Calcipotriene Combination for Actinic Keratosis and Superficial Basal Cell Carcinoma Patients 5 FU: Effective Treatment for Actinic Keratosis and Skin Conditions By Nathalie De Champlain Millions of Americans* annually could be candidates for topical 5-FU treatment for actinic keratosis or superficial basal […]
Thousands of Providers Dispense Dermatological Topical Rx in Their Offices. Here’s Why.
SKNV Rx Insights Thousands of Providers Dispense Dermatological Topical Rx in Their Offices. Here’s Why. By Ava Malkin As an FDA-Registered 503B Outsourcing Facility, SKNV produces over 120+ customized topical medication formulations dedicated to addressing a variety of dermatological conditions. To ensure that providers have a convenient process of prescribing our medications to patients and […]
The Power of Customized Medications in Dermatology: A Conversation with Dr. Steven Kolenik
SKNV Rx Insights The Power of Customized Medications in Dermatology: A Conversation with Dr. Steven Kolenik By Nathalie de Champlain, Chief Marketing Officer, SKNV As dermatology continues to evolve, the power of customization brings an incredible experience for dermatologists, providers, and patients. Our mission at SKNV is not only to improve patient outcomes but also […]